Bank Of America Corp Cassava Sciences Inc Transaction History

Bank Of America Corp

  • $1.33 Trillion
  • Q2 2025

A detailed history of Bank Of America Corp transactions in Cassava Sciences Inc stock. As of the latest transaction made, Bank Of America Corp holds 29,203 shares of SAVA stock, worth $67,750. This represents 0.0% of its overall portfolio holdings.

Number of Shares
29,203
Previous 116,820 75.0%
Holding current value
$67,750
Previous $175,000 70.29%
% of portfolio
0.0%
Previous 0.0%

Shares

16 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2025

Aug 14, 2025
SELL
$1.19 - $2.24 $104,264 - $196,262
-87,617 Reduced 75.0%
29,203 $52,000
Q1 2025

May 15, 2025
SELL
$1.5 - $3.02 $543,612 - $1.09 Million
-362,408 Reduced 75.62%
116,820 $175,000
Q4 2024

Feb 14, 2025
BUY
$2.29 - $32.18 $889,376 - $12.5 Million
388,374 Added 427.47%
479,228 $1.13 Million
Q3 2024

Nov 14, 2024
SELL
$9.57 - $35.08 $284,583 - $1.04 Million
-29,737 Reduced 24.66%
90,854 $2.67 Million
Q2 2024

Aug 14, 2024
SELL
$12.35 - $26.11 $287,927 - $608,728
-23,314 Reduced 16.2%
120,591 $1.49 Million
Q1 2024

May 15, 2024
SELL
$18.44 - $26.41 $1.66 Million - $2.38 Million
-90,036 Reduced 38.49%
143,905 $2.92 Million
Q4 2023

Feb 14, 2024
BUY
$12.64 - $30.11 $761,319 - $1.81 Million
60,231 Added 34.67%
233,941 $5.27 Million
Q2 2023

Aug 14, 2023
SELL
$21.59 - $27.88 $972,823 - $1.26 Million
-45,059 Reduced 20.6%
173,710 $4.26 Million
Q1 2023

May 12, 2023
BUY
$23.46 - $36.44 $2.76 Million - $4.29 Million
117,742 Added 116.55%
218,769 $5.28 Million
Q4 2022

Feb 10, 2023
SELL
$27.82 - $44.16 $4.59 Million - $7.29 Million
-164,973 Reduced 62.02%
101,027 $2.98 Million
Q3 2022

Nov 14, 2022
BUY
$16.33 - $51.06 $2.02 Million - $6.31 Million
123,547 Added 86.73%
266,000 $11.1 Million
Q2 2022

Aug 12, 2022
BUY
$17.22 - $38.47 $1.94 Million - $4.34 Million
112,808 Added 380.53%
142,453 $4.01 Million
Q1 2022

May 16, 2022
SELL
$32.6 - $53.05 $8 Million - $13 Million
-245,462 Reduced 89.22%
29,645 $1.1 Million
Q4 2021

Feb 08, 2022
BUY
$36.77 - $90.91 $4.54 Million - $11.2 Million
123,437 Added 81.39%
275,107 $12 Million
Q3 2021

Nov 15, 2021
BUY
$41.79 - $135.3 $5.32 Million - $17.2 Million
127,274 Added 521.7%
151,670 $9.42 Million
Q2 2021

Sep 13, 2021
BUY
$32.15 - $89.72 $784,331 - $2.19 Million
24,396 New
24,396 $2.09 Million

Others Institutions Holding SAVA

# of Institutions
131
Shares Held
14.2M
Call Options Held
962K
Put Options Held
864K
View Full List

About CASSAVA SCIENCES INC

SAVA Quotes by TradingView
  • Ticker SAVA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 40,097,900
  • Market Cap $93M
  • Description
  • Cassava Sciences, Inc., a clinical stage biotechnology company, develops drugs for neurodegenerative diseases. Its lead therapeutic product candidate is simufilam, a small molecule drug, which is completed Phase 2b clinical trial; and investigational diagnostic product candidate is SavaDx, a blood-based biomarker/diagnostic to detect Alzheimer's...
More about SAVA
Track This Portfolio

Track Bank Of America Corp Portfolio

Follow Bank Of America Corp and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Bank Of America Corp , based on Form 13F filings with the SEC.

News

Stay updated on Bank Of America Corp with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email